ArticleHealth psychology research2022

Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update.

Hannah W Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.